Ann: Appendix 4C - quarterly, page-8

Haha. Cute.

Patients merely means anyone who has been prescribed AGH product. There is zero mention of patient RETENTION.
Doesn't matter how many patients you claim to have if your revenue is only up 5% quarter on quarter.

If anything, that draws ALARM BELLS. If you believe that all 7000+ patients are still actively taking AGH product how come the revenue is only up 5%? Doesn't add up.

In reality, it means patient retention is far lower and has never been mentioned by AGH.
Whilst they may have added 593 patients this quarter, again it draws dire implications if the revenue is only up 5% despite adding so many patients. That's mathematically impossible.

What is obvious here is that out of those 7,295 patients how many are coming back for more?
Never mentioned.

5% revenue growth is rather inexcusable. Either way, it matters not what a few posts on Hotcopper say.
The market will decide how it likes the quarterly.